Pharmaceutical Technology2h
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Photos accompanying this announcement are available at: ...
FiercePharma2h
Amid takeover talk, SpringWorks scores FDA nod for rare genetic disease treatment Gomekli
Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
US FDA approves SpringWorks' genetic disorder drug
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
As a woman with facial differences, I'm grateful for Sebastian Stan's award speech.
A Jacksonville woman pens a letter of gratitude to actor Sebastian Stan for his recent words on normalizing disfigurement and ...
SpringWorks shares rise on FDA nod for GOMEKLI
The FDA's green light for GOMEKLI is a significant achievement for SpringWorks, especially as it comes with a rare pediatric disease priority review voucher, which could be valued at around $100 ...
FDA approves SpringWorks’ mirdametinib for adult and pediatric NF1 patients
The Food and Drug Administration approved mirdametinib, brand name Gomekli, from SpringWorks Therapeutics (SWTX), a kinase inhibitor, for adult ...
SpringWorks Therapeutics confirms FDA approval of Gomekli
SpringWorks Therapeutics (SWTX) announced that the U.S. FDA has approved Gomekli, SpringWorks’ MEK inhibitor, for the treatment of adult and ...
HRS: Cupid’s undie run, a blushing way to raise money for NF
PORTSMOUTH, Va. (WAVY) – In 2010, a group of enthusiastic supporters ran through the cold in Washington, D.C., dropping their pants to raise money for research to help end neurofibromatosis (NF), a ...
We Live In Time is Max’s #1 most-watched movie – here are 7 more powerful A24 films with over 91% on Rotten Tomatoes
Since We Live in Time packs all the emotions, I felt it's only appropriate that I give you a range of new Max movies that reflect everything A24 has to offer – whether that's a coming-of-age story, a ...
SpringWorks gets FDA approval for mirdametinib
SpringWorks Therapeutics (NASDAQ:SWTX), which is reportedly in takeover talks with Merck KGaA (OTCPK:MKGAF) (OTCPK:MKKGY), has received FDA approval for the drug mirdametinib for the treatment of ...